Loading organizations...

§ Venture Capital · VIA GIOSUE CARDUCCI, 36, 20123 MILANO, ITALY
Battery software developer providing advanced tools for automakers and device makers to optimize battery performance, lifespan, and charging.
Breath Diagnostics Inc. is a medical technology company developing non-invasive breath tests. Its core product utilizes proprietary OneBreath™ technology, serving as an an adjunctive diagnostic tool for lung cancer screening. This approach seeks to enhance early detection through a less intrusive and more accessible method, advancing diagnostic precision in critical health assessments.
The company formally established as a Delaware corporation on July 30, 2015, co-founded by Xiao-An Fu and Victor van Berkel. Their insight arose from the pressing need for advanced, non-invasive diagnostic solutions in oncology, driving them to innovate breath analysis for medical diagnostics.
Breath Diagnostics Inc. serves the medical community and patients, offering an innovative option for lung cancer screening. The company envisions transforming the early disease detection landscape, making sophisticated diagnostic capabilities broadly available through its accessible, breath-based technology. It aims to significantly improve screening outcomes and patient care.
Breath 80 has 1 tracked investment across 1 company. The latest tracked deal is $6.3M Series A in Kither Biotech in July 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 9, 2019 | Kither Biotech | $6.3M Series A | — | Laura Iris Ferro, Stefano Buono, ACE Venture, Club Degli Investitori, Elysia Capital, Ersel, Invitalia Ventures |